Sommario

• • ·A commission on vector-borne infections

    Pagina :827

     
• • ·Long-term infectious sequelae after SARS-CoV-2 infection should be considered in mild cases too

    Pagina :828-829

    Gabriel Chodick

     
• • ·Expanding human papillomavirus vaccine options

    Pagina :829-830

    Alex Vorsters, Edina Amponsah-Dacosta

     
• • ·DoxyPEP open-label extension: well done is better than well said

    Pagina :830-832

    Ann N Burchell, Troy Grennan

     
• • ·High-dose primaquine reduces vivax relapses: time for change

    Pagina :832-833

    Robert J Commons, Cindy S Chu

     
• • ·Tackling the burden of β-lactam allergy labels

    Pagina :834-835

    Philip H Li, Kimberly G Blumenthal

     
• • ·Closing the pertussis immunity gap: vaccine equity saves infant lives

    Pagina :835-836

    Rudzani Muloiwa, Kevin D Forsyth

     
• • ·Individualised duration of treatment in febrile urinary tract infection: ready for prime time?

    Pagina :837-838

    Jesús Rodríguez-Baño, Zaira R Palacios-Baena

     
• • ·Long COVID treatment trials: still more questions than answers?

    Pagina :838-840

    Carolyn T Bramante, Clifford J Rosen

     
• • ·Balancing promise and peril: risk management in India’s BPaL introduction

    Pagina :840-841

    Praveen K Tirlangi, Nitin Gupta

    
• • ·COVID-19 mortality in Africa and Asia

    Pagina :e439

    Sandro Vento

    
• • ·COVID-19 mortality in Africa and Asia – Authors’ reply

    Pagina :e440

    Philip Bejon, Ambrose Agweyu, Isabella Oyier, Mainga Hamaluba, Dorcas Kamuya, Sam Kinyanjui, Edwine Barasa

    
• • ·Neuroinvasive Oropouche virus in a patient with HIV from extra-Amazonian Brazil

    Pagina :e441

    Felipe Donateli Gatti, Joana Zorzal Nodari, Thiago de Jesus Sousa, Gabriela Colombo de Mendonça, Eric Arrivabene Tavares, Iara Almeida Pinto, Julia Del Piero Pereira, Joaquim Batista Ferreira Filho, Valéria Pereira Cabral, Suwellen Sardinha Dias de Azevedo, Anna Clara Gregório Có, Jaqueline Pegoretti Goulart, Felipe Gomes Naveca, Edson Delatorre, Rodrigo Ribeiro-Rodrigues

     
• • ·Virological characteristics of the SARS-CoV-2 NB.1.8.1 variant

    Pagina :e443

    Keiya Uriu, Kaho Okumura, Yoshifumi Uwamino, Luo Chen, Jarel Elgin Tolentino, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Jumpei Ito, Kei Sato, The Genotype to Phenotype Japan (G2P-Japan) Consortium

     
• • ·Correction to Lancet Infect Dis 2024; 24: 1201–12

    Pagina :e444

    
• • ·Correction to Lancet Infect Dis 2025; published online June 20. https://doi.org/10.1016/S1473-3099(25)00240-3

    Pagina :e444

    
• • ·Correction to Lancet Infect Dis 2025; 25: 494

    Pagina :e444

    
• • ·Global progress on neglected tropical diseases

    Pagina :e445

    Timothy Jesudason

     
• • ·World-first gonorrhoea vaccine to be rolled out in England

    Pagina :e446

    Tony Kirby

    
• • ·Africa to integrate cholera and mpox response

    Pagina :e447

    Esther Nakkazi

     
• • ·Debt crisis hinders infectious disease response

    Pagina :e448

    Talha Burki

     
• • ·Infectious disease surveillance update

    Pagina :e449

    Cahal McQuillan

    Mappa Mappa
• • ·Research in brief

    Pagina :e450

    Priya Venkatesan

    Mappa Mappa
• • ·Elise Sampson

    Pagina :842

    Sanjeet Bagcchi

     
• • ·Xiang-Sheng Chen—controlling STIs in China

    Pagina :843

    Tony Kirby

     
• • ·COVID-19: the challenges of a digital pandemic

    Pagina :844

    Henrietta Dunsmuir

     
• • ·Women of the shadow pandemic in Zimbabwe

    Pagina :845

    Phoebe Ashley-Norman

     
• • ·Ageing in a pandemic

    Pagina :846

    Hollie Sherwood-Martin

     
• • ·Rates of infection with other pathogens after a positive COVID-19 test versus a negative test in US veterans (November, 2021, to December, 2023): a retrospective cohort study

    Pagina :847-860

    Miao Cai, Evan Xu, Yan Xie, Ziyad Al-Aly

    Riassunto Riassunto Mappa Mappa   
• • ·Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9–14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial

    Pagina :861-872

    Tsiri Agbenyega, Anne E Schuind, Samuel Adjei, Kalpana Antony, John J Aponte, Patrick B Y Buabeng, John D Clemens, Lokman Hossain, Troy J Kemp, Laina D Mercer, Ligia A Pinto, Firdausi Qadri, Kristen Sukraw, Niranjan Bhat, Khalequ Zaman

    Riassunto Riassunto Mappa Mappa   
• • ·Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension

    Pagina :873-883

    Anne F Luetkemeyer, Deborah Donnell, Stephanie E Cohen, Julia C Dombrowski, Cole Grabow, Grace Haser, Clare Brown, Chase Cannon, Cheryl Malinski, Rodney Perkins, Melody Nasser, Carolina Lopez, Robert J Suchland, Eric Vittinghoff, Susan P Buchbinder, Hyman Scott, Edwin D Charlebois, Diane V Havlir, Olusegun O Soge, Connie Celum

    Riassunto Riassunto Mappa Mappa   
• • ·14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy study

    Pagina :884-895

    Virak Eng, Dysoley Lek, Sitha Sin, Lionel Brice Feufack-Donfack, Agnes Orban, Jeremy Salvador, Dynang Seng, Sokleap Heng, Nimol Khim, Kieran Tebben, Claude Flamand, Cecile Sommen, Rob W van der Pluijm, Michael White, Benoit Witkowski, David Serre, Jean Popovici

    Riassunto Riassunto Mappa Mappa   
• • ·The burden of β-lactam allergy labels in health care: a systematic review and meta-analysis

    Pagina :896-908

    Mengyuan Fu, Lin Hu, Kexin Han, Gengchen Wang, Huangqianyu Li, Zhuo Ma, Haishaerjiang Wushouer, Luwen Shi, Xiaodong Guan

    Riassunto Riassunto Mappa Mappa   
• • ·The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial

    Pagina :909-924

    Anja Saso, Ebrima Kanteh, David Jeffries, Michael Okoye, Nuredin Mohammed, Michelle Kumado, Sophie Roetynck, Haddijatou Jobe, Amadou Faal, Elishia Roberts, Pieter Gageldonk, Anne-Marie Buisman, Janeri Fröberg, Breeze Cavell, Elodie Lesne, Alex-Mikael Barkoff, Qiushui He, Kiarash Tanha, Sagida Bibi, Dominic Kelly, Dimitri Diavatopoulos, Beate Kampmann, Gambian Pertussis Study Team, members of the PERISCOPE consortium, Andrew Gorringe, Aru-Kumba Baldeh, Coos Baakman, Professor Guy Berbers, Hadijatou J Sallah, Irina Tcherniaeva, Jussi Mertsola, Karamo Conteh, Louisa Dixon, Marcela Silerova, Marc Eleveld, Marien de Jonge, Marta Pinto, Professor Martijn A Huynen, Martina Ochs, Modou Fofana, Nikki Mcstraw, Patricia Londono, Rachel Halkerston, Ronald de Groot, Thushan I. de Silva, Ulrich Heininger, Xinxue Liu

    Riassunto Riassunto Mappa Mappa   
• • ·Efficacy and safety of individualised versus standard 10-day antibiotic treatment in children with febrile urinary tract infection (INDI-UTI): a pragmatic, open-label, multicentre, randomised, controlled, non-inferiority trial in Denmark

    Pagina :925-935

    Naqash Javaid Sethi, Emma Louise Malchau Carlsen, Abdullah Tabassum, Dina Cortes, Simone Mark.øw, Ida Maria Schmidt, Mette Marie Christensen, Ann-Britt Kiholm Kirkedal, Claudia Mau Kai, Charlotte Kjær Bjerre, Lise Heilmann Jensen, Maria Antonova, Signe Sønderkær, Maren Johanne Heilskov Rytter, Gry Tordrup, Tatjana Zaharov, Line Thousig Sehested, Ulrikka Nygaard

    Riassunto Riassunto Mappa Mappa   
• • ·Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial

    Pagina :936-946

    Mitsuaki Sawano, Bornali Bhattacharjee, César Caraballo, Rohan Khera, Shu-Xia Li, Jeph Herrin, Dany Christian, Andreas Coppi, Frederick Warner, Julie Holub, Yashira Henriquez, Maria A Johnson, Theresa B Goddard, Erica Rocco, Amy C Hummel, Mohammad AL Mouslmani, William Brenham Hooper, David F Putrino, Kevin D Carr, Lawrence Charnas, Magdia De Jesus, Dale Nepert, Paula Abreu, Frank W Ziegler, John A Spertus, Akiko Iwasaki, Harlan M Krumholz

    Riassunto Riassunto Mappa Mappa   
• • ·Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies

    Pagina :e451

    Per Ljungman, Sophie Alain, Roy F Chemaly, Hermann Einsele, Federica Galaverna, Hans H Hirsch, Alicja Sadowska-Klasa, David Navarro, Jan Styczynski, Rafael de la Camara

    Riassunto Riassunto Mappa Mappa   
• • ·Rethinking the evidence on COVID-19 in Africa

    Pagina :e463

    Philip Bejon, Ambrose Agweyu, L Isabella Ochola-Oyier, Mainga Hamaluba, Dorcas Kamuya, Sam Kinyanjui, Edwine Barasa

    Riassunto Riassunto Mappa Mappa
• • ·Intention-to-diagnose and distinct research foci in diagnostic accuracy studies

    Pagina :e472

    Scott R Evans, Gene Pennello, Shanshan Zhang, Yixuan Li, Yike Wang, Qian Cao, Lauren Komarow, Toshimitsu Hamasaki, Victoria Petrides, Kristen Meier, Norberto Pantoja Galicia, Vance G Fowler, Helen W Boucher, Sarah B Doernberg, Ritu Banerjee, Maria Helena Rigatto, Barry N Kreiswirth, Robert A Bonomo, Henry F Chambers, Robin Patel

    Riassunto Riassunto Mappa Mappa   
• • ·Maternal mastitis and streptococcal toxic shock syndrome risk from breastfeeding children with scarlet fever: case report and literature review

    Pagina :e482

    Sonja Dahmann, Maximilian Kueckelhaus, Philipp Wiebringhaus, David Kampshoff, Carl Opitz, Joke Tio, Michael Ney, Andreas Itzek, Tobias Hirsch, Alexander Dermietzel

    Riassunto Riassunto Mappa Mappa  
• • ·Recognising Aspergillus udagawae in a child with chronic granulomatous disease

    Pagina :e489

    Qi Gao, Fei-Na Li, Fang Dong, Xiao-Min Duan, Jin-Gang Gui, Wen-Jun Mou, Xing-Feng Yao, Hao Wang, Lin Sun, Ju Yin

    Mappa Mappa